1.A pediatric case of anaphylactic shock induced by tipepidine hibenzate (Asverin)
Hirotake TAKAI ; Izumi KATO ; Kanako MITSUNAGA ; Mayumi HARA ; Takahiro KODAMA ; Masaki KANAZAWA ; Masaru TERAI
Asia Pacific Allergy 2018;8(4):e37-
Tipepidine hibenzate (Asverin) is commonly used as an antitussive drug for acute and chronic cough in various age groups and is generally safe and well-tolerated. However, we experienced a case of tipepidine hibenzate-induced anaphylactic shock in a 1-year-old boy. After ingesting cold medication including tipepidine hibenzate, the patient presented with generalized erythema and urticaria, swollen face, coughing, wheezing and vomiting, together with hypotension and a decreased level of consciousness. To identify the culprit drug, we performed skin prick tests (SPTs) and oral drug provocation tests (DPTs). SPTs revealed a negative reaction for all drugs, but DPTs caused a positive reaction only for a full therapeutic dose of tipepidine hibenzate. Physicians need to consider tipepidine hibezate as a culprit drug when anaphylaxis occurs after taking anticough or common cold medication.
Anaphylaxis
;
Child
;
Common Cold
;
Consciousness
;
Cough
;
Drug Hypersensitivity
;
Erythema
;
Humans
;
Hypotension
;
Male
;
Respiratory Sounds
;
Skin
;
Urticaria
;
Vomiting
2.Predictors for Diarrhea After Administration of Naldemedine: Analysis Focusing on the Administration Period of Opioid Analgesics Before the Start of Naldemedine
Junya HASHIZUME ; Emi RYU ; Seiichi NOSE ; Kei MIYANAGA ; Reiko KISHIKAWA ; Tadahiro NAKAMURA ; Takahiro MURO ; Yukinobu KODAMA ; Haruna YAMASHITA ; Koji ISHII ; Hitoshi SASAKI
Palliative Care Research 2020;15(2):101-109
Purpose: Naldemedine is a peripheral µ-opioid receptor antagonist, including the treatment of opioid-induced constipation (OIC) . However, diarrhea is known as its side effect. We conducted a study focusing on the administration period of opioid analgesics before the start of naldemedine to clear predictors of diarrhea due to Naldemedine. Method: All data were retrospectively collected from the electronic medical record system. We investigated patients who initially administrated naldemedine at Nagasaki University Hospital from June 1 2017 to March 31 2019. Result: One hundred thirty-two patients were subject of investigation. The incidence of diarrhea was 25.0%. The result of the multivariate analysis showed that significant predictors of diarrhea were associated with the opioid analgesics usage period longer than 7 days before naldemedine initiation (odds ratio: 3.76, 95% confidence interval: 1.53-9.20, p=0.004). Discussion: When naldemedine was used for OIC, diarrhea may be avoided by using within 7 days after opioid analgesics.